Imaging genomics

British Medical Bulletin - Tập 65 Số 1 - Trang 259-270 - 2003
Ahmad R. Hariri1, Daniel R. Weinberger
1Clinical Brain Disorders Branch, Intramural Research Program, National Institute of Mental Health, National Institutes of Health, Bethesda, Maryland 20892, USA.

Tóm tắt

Từ khóa


Tài liệu tham khảo

Venter JC, Adams MD, Myers EW et al. The sequence of the human genome. Science2001; 291: 1304–51

Lander ES, Linton LM, Birren B et al. Initial sequencing and analysis of the human genome. Nature2001; 409: 860–921

McGuffin P, Riley B, Plomin R. Genomics and behavior. Toward behavioral genomics. Science2001; 291: 1232–49

Moldin SO, Gottesman II. At issue: genes, experience, and chance in schizophrenia – positioning for the 21st century. Schizophr Bull1997; 23: 547–61

Emahazion T, Feuk L, Jobs M et al. SNP association studies in Alzheimer's disease highlight problems for complex disease analysis. Trends Genet2001; 17: 407–13

Malhotra AK, Goldman D. Benefits and pitfalls encountered in psychiatric genetic association studies. Biol Psychiatry1999; 45: 544–50

Glatt CE, Freimer NB. Association analysis of candidate genes for neuropsychiatric disease: the perpetual campaign. Trends Genet2002; 18: 307–12

Vogel F, Schalt E, Kruger J, Propping P, Lehnert KF. The electroencephalogram (EEG) as a research tool in human behavior genetics: psychological examinations in healthy males with various inherited EEG variants. Hum Genet1979; 47: 1–45

Axelrod BN. Are normative data from the 64-card version of the WCST comparable to the full WCST? Clin Neuropsychol2002; 16: 7–11

Whalen PJ, Bush G, McNally RJ et al. The emotional counting Stroop paradigm: a functional magnetic resonance imaging probe of the anterior cingulate affective division. Biol Psychiatry1998; 44: 1219–28

Saunders AM, Strittmatter WJ, Schmechel D et al. Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology1993; 43: 1467–72

Corder EH, Saunders AM, Strittmatter WJ et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science1993; 261: 921–3

Small GW, Mazziotta JC, Collins MT et al. Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer disease. JAMA1995; 273: 942–7

Reiman EM, Caselli RJ, Yun LS et al. Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E. N Engl J Med1996; 334: 752–8

National Institute on Aging/Alzheimer's Association Working Group. Apolipoprotein E genotyping in Alzheimer's disease. Lancet1996; 347: 1091–5

Bookheimer SY, Strojwas MH, Cohen MS et al. Patterns of brain activation in people at risk for Alzheimer's disease. N Engl J Med2000; 343: 450–6

Rausch R, Babb TL. Hippocampal neuron loss and memory scores before and after temporal lobe surgery for epilepsy. Arch Neurol1993; 50: 812–7

Weinshilboum RM, Otterness DM, Szumlanski CL. Methylation pharmacogenetics: catechol O-methyltransferase, thiopurine methyltransferase, and histamine N-methyltransferase. Annu Rev Pharmacol Toxicol1999; 39: 19–52

Lewis DA, Sesack SR, Levey AI, Rosenberg DR. Dopamine axons in primate prefrontal cortex: specificity of distribution, synaptic targets, and development. Adv Pharmacol1998; 42: 703–6

Goldman-Rakic PS. Regional and cellular fractionation of working memory. Proc Natl Acad Sci USA1996; 93: 13473–80

Egan MF, Goldberg TE, Kolachana BS et al. Effect of COMT Val108/158Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci USA2001; 98: 6917–22

Callicott JH, Mattay VS, Bertolino A et al. Physiological characteristics of capacity constraints in working memory as revealed by functional MRI. Cereb Cortex1999; 9: 20–6

Cohen JD, Perlstein WM, Braver TS et al. Temporal dynamics of brain activation during a working memory task. Nature1997; 386: 604–8

Eberhard G, Ross S, Saaf J, Wahlund B, Wetterberg L. Psychoses in twins. A 10 year clinical and biochemical follow-up study. Schizophr Res1989; 2: 367–74

Nurnberger Jr JI, Foroud T. Genetics of bipolar affective disorder. Curr Psychiatry Rep2000; 2: 147–57

Lesch KP, Bengel D, Heils A et al. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science1996; 274: 1527–31

Heinz A, Jones DW, Mazzanti C et al. A relationship between serotonin transporter genotype and in vivo protein expression and alcohol neurotoxicity. Biol Psychiatry2000; 47: 643–9

Little KY, McLaughlin DP, Zhang L et al. Cocaine, ethanol, and genotype effects on human midbrain serotonin transporter binding sites and mRNA levels. Am J Psychiatry1998; 155: 207–13

Melke J, Landen M, Baghei F et al. Serotonin transporter gene polymorphisms are associated with anxiety-related personality traits in women. Am J Med Genet2001; 105: 458–63

Du L, Bakish D, Hrdina PD. Gender differences in association between serotonin transporter gene polymorphism and personality traits. Psychiatr Genet2000; 10: 159–64

Garpenstrand H, Annas P, Ekblom J, Oreland L, Fredrikson M. Human fear conditioning is related to dopaminergic and serotonergic biological markers. Behav Neurosci2001; 115: 358–64

Lesch KP, Mossner R. Genetically driven variation in serotonin uptake: is there a link to affective spectrum, neurodevelopmental, and neurodegenerative disorders? Biol Psychiatry1998; 44: 179–92

Ressler KJ, Nemeroff CB. Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders. Depress Anxiety2000; 12 Suppl 1: 2–19

Ball D, Hill L, Freeman B et al. The serotonin transporter gene and peer-rated neuroticism. Neuroreport1997; 8: 1301–4

Ebstein RP, Segman R, Benjamin J et al. 5-HT2C (HTR2C) serotonin receptor gene polymorphism associated with the human personality trait of reward dependence: interaction with dopamine D4 receptor (D4DR) and dopamine D3 receptor (D3DR) polymorphisms. Am J Med Genet1997; 74: 65–72

Katsuragi S, Kunugi H, Sano A et al. Association between serotonin transporter gene polymorphism and anxiety-related traits. Biol Psychiatry1999; 45: 368–70

Flory JD, Manuck SB, Ferrell RE et al. Neuroticism is not associated with the serotonin transporter (5-HTTLPR) polymorphism. Mol Psychiatry1999; 4: 93–6

Deary IJ, Battersby S, Whiteman MC et al. Neuroticism and polymorphisms in the serotonin transporter gene. Psychol Med1999; 29: 735–9

Ohara K, Nagai M, Tsukamoto T, Tani K, Suzuki Y. Functional polymorphism in the serotonin transporter promoter at the SLC6A4 locus and mood disorders. Biol Psychiatry1998; 44: 550–4

Hariri AR, Mattay VS, Tessitore A et al. Serotonin transporter genetic variation and the response of the human amygdala. Science2002; 297: 400–3

Hariri AR, Tessitore A, Mattay VS, Fera F, Weinberger DR. The amygdala response to emotional stimuli: a comparison of faces and scenes. Neuroimage2002; 17: 317–23

Hariri AR, Mattay VS, Tessitore A et al. Dextroamphetamine modulates the response of the human amygdala. Neuropsychopharmacology2002; 27: 1037–41

Davis M, Whalen PJ. The amygdala: vigilance and emotion. Mol Psychiatry2001; 6: 13–34